Enzon Pharmaceuticals Stock Price and Value Analysis

Should you buy Enzon Pharmaceuticals stock? (Other OTC:ENZN). Let's see how it does in our automated value investing analysis system.

  • This company is solid.
  • This stock looks overpriced.
  • This company has wild ups and downs.
  • This company is not making money.
  • This company pays no dividend.

Inside the ENZN Numbers

ENZN Price
(Enzon Pharmaceuticals stock price per share)
[?] PE Ratio versus Sector 23% lower than other Healthcare stocks
[?] PE Ratio versus Industry 73% lower than other Biotechnology stocks
[?] Cash Yield 144.55%
[?] Free Cash Flow Jitter 79%

Is Enzon Pharmaceuticals Stock on Sale?

Based on our analysis, we believe that you should not buy Enzon Pharmaceuticals right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy ENZN Stock?

Does Enzon Pharmaceuticals have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.